Filings & corporate actions
- 21 JulresultsResults · Q1 FY27 · consolidated and standalone+6.5%NSE
- 20 JulshareholdingShareholding · 30 Jun 2026+1.0%NSE
- 29 MayresultsResults · Q4 FY26 · consolidated and standalone-14.7%NSE
- 21 AprshareholdingShareholding · 31 Mar 2026-0.4%NSE
- 17 JanresultsResults · Q3 FY26 · consolidated and standalone+4.8%NSE
- 8 JanshareholdingShareholding · 7 Jan 2026-1.2%NSE
- 8 JanshareholdingShareholding · 31 Dec 2025-1.2%NSE
Reaction to results · all yearsrose on day 0 in 7 of 22 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 21 Jul 2026 | +6.5% | +11.8% | +8.5% | 12.7× |
| Q4 FY26 | 29 May 2026 | -14.7% | -18.5% | -15.7% | 10.7× |
| Q3 FY26 | 17 Jan 2026 | +4.8% | -10.9% | -9.5% | 6.3× |
| Q2 FY26 | 16 Oct 2025 | +19.3% | +28.7% | +9.7% | 61.0× |
| Q1 FY26 | 15 Jul 2025 | -8.6% | -11.9% | -17.1% | 17.7× |
| Q4 FY25 | 7 May 2025 | +2.0% | +8.2% | +21.6% | 6.1× |
| Q3 FY25 | 24 Jan 2025 | -5.0% | -14.5% | -21.3% | 0.0× |
| Q2 FY25 | 25 Oct 2024 | -2.8% | +4.9% | -1.6% | 1.1× |
| Q1 FY25 | 5 Aug 2024 | +0.6% | +1.0% | +24.9% | 1.1× |
| Q4 FY24 | 15 May 2024 | -1.9% | -1.9% | +1.5% | 0.9× |
| Q3 FY24 | 8 Feb 2024 | -3.6% | -7.2% | -13.3% | 1.6× |
| Q2 FY24 | 4 Nov 2023 | +1.3% | -0.2% | 0.0% | 1.7× |
| Q1 FY24 | 10 Aug 2023 | -2.2% | -5.7% | +10.7% | 1.7× |
| Q4 FY23 | 24 May 2023 | -0.7% | +19.2% | +17.2% | 1.3× |
| Q3 FY23 | 4 Feb 2023 | -2.0% | -4.5% | -6.1% | 0.1× |
| Q2 FY23 | 11 Nov 2022 | -3.4% | -15.1% | -34.7% | 1.2× |
| Q1 FY23 | 13 Aug 2022 | -2.3% | -2.1% | -3.3% | 2.7× |
| Q4 FY22 | 29 May 2022 | -1.6% | +4.6% | -4.5% | 0.6× |
| Q3 FY22 | 13 Feb 2022 | -6.6% | -10.6% | -12.4% | 1.7× |
| Q2 FY22 | 11 Nov 2021 | -2.1% | -15.0% | -8.7% | 1.3× |
| Q1 FY22 | 1 Aug 2021 | +5.0% | -4.8% | -2.4% | 0.3× |
| Q4 FY21 | 17 Jun 2021 | -4.5% | +5.4% | +4.5% | 3.1× |
| Average | -1.0% | -1.8% | -2.4% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q1 FY27
CSV| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +43.5% | +20.5% | +3.8% | — | — | — |
| Profit | +199.3% | — | +2.7% | — | — | — |
Key data
CSVDelivery percentage
Over the last 20 sessions NURECA settled 100.0% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 65.6%, so recent sessions are running 34.4 points higher than usual. That is the highest reading in the 1,385 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | -0.15% | -6.62% | +1.79% | +48.81% | +42.37% | +48.27% |
Valuation
CSVOwnership
CSVQuarterly results · consolidated
CSV| Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 37.7 | 39.6 | 35.4 | 40.3 |
| YoY chg | +21.0% | +49.8% | +11.5% | +18.0% |
| Net profit (₹ Cr) | 3.6 | 3.7 | (6.1) | 3.1 |
| YoY chg | — | — | -346.9% | +277.4% |
| Net margin | 9.6% | 9.4% | -17.2% | 7.6% |
| EPS | 3.63 | 3.91 | -6.45 | 3.21 |
Shareholding over time
CSVBy quarter
30 Jun 2026 · promoter 68.09% · public 31.91%- Promoter
- Public and others
- Promoter
- 68.09%
- Public
- 31.91%
- Promoter change
- 0.00 pp
- Filed
- 20 Jul 2026
- FII
- 0.11%
- DII
- 0.24%
- Promoter pledged
- 0.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV| Q2 FY24 | Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25A | Q4 FY25A | Q1 FY26 | Q2 FY26R | Q3 FY26 | Q4 FY26A | Q1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 31.4 | 22.4 | 17.0 | 20.3 | 31.2 | 26.5 | 31.7 | 34.2 | 37.7 | 39.6 | 35.4 | 40.3 | |
| Other income | 3.2 | 5.9 | (1.3) | 5.8 | 3.2 | 1.5 | 2.0 | 2.6 | 2.3 | 2.2 | 1.0 | 1.8 | |
| Total income | 34.6 | 28.3 | 15.7 | 26.1 | 34.4 | 27.9 | 33.7 | 36.7 | 40.1 | 41.8 | 36.4 | 42.2 | |
| Total expenses | 30.6 | 27.3 | 22.2 | 23.4 | 34.4 | 31.2 | 31.7 | 35.5 | 35.5 | 37.2 | 41.9 | 37.7 | |
| └ Finance costs | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.6 | 0.2 | 0.5 | 0.3 | 0.3 | 0.2 | |
| └ Depreciation | 0.6 | 0.6 | 0.6 | 0.7 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.6 | |
| Profit before tax | 3.9 | 0.9 | (6.5) | 2.6 | (0.1) | (3.3) | 2.1 | 1.2 | 4.6 | 4.7 | (5.5) | 4.4 | |
| Tax expense | 1.0 | 0.8 | (2.3) | 1.0 | 0.4 | (0.5) | (0.4) | 0.4 | 1.0 | 0.9 | 0.6 | 1.4 | |
| Net profit | 2.9 | 0.2 | (4.1) | 1.7 | (0.5) | (2.8) | 2.5 | 0.8 | 3.6 | 3.7 | (6.1) | 3.1 | |
| EPS | 2.90 | 0.16 | -4.15 | 1.66 | -0.48 | -2.80 | 2.47 | 0.81 | 3.63 | 3.91 | -6.45 | 3.21 | |
| Net margin | 9.23% | 0.74% | -24.43% | 8.20% | -1.55% | -10.58% | 7.77% | 2.38% | 9.61% | 9.42% | -17.21% | 7.60% | |
| PBT margin | 12.48% | 4.22% | -38.14% | 12.92% | -0.24% | -12.29% | 6.46% | 3.60% | 12.18% | 11.77% | -15.57% | 10.99% | |
| Tax rate | 26.02% | 82.54% | — | 36.54% | — | — | -20.28% | 33.96% | 21.09% | 19.94% | — | 30.79% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 21 Jul 2026.
NURECA at a glance
- NURECA closed at ₹338.55 on 6 Oct 2026, -0.15% on the day, +48.3% over one year, 10.0% below its 52-week high of ₹376.
- Delivery was 100.0% of traded quantity on 6 Oct 2026, the 100th percentile of its own 1,385 sessions with a reading (20-session average 100.0%, 1-year average 65.6%).
- Market capitalisation is ₹323 crore at a trailing P/E of 62.7 (trailing EPS ₹5.4).
- Q1 FY27 results (consolidated, filed 21 Jul 2026): revenue ₹40 crore (+18.0% year on year), net profit ₹3 crore (+277.4%); the price moved +6.5% on the first session after.
- Promoters held 68.09% at 30 Jun 2026, unchanged on the previous filing.
- Q2 FY27 results are expected between 16 Oct 2026 and 11 Nov 2026, going by past filing dates — an estimate, not an announcement.
About
CSVPrices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
Other NSE equitys by turnover
CSV- MANORGMangalam Organics Limited436.10+0.88%
- CONSOFINVTConsolidated Finvest & Holdings Limited283.20-0.37%
- SPECIALITYSpeciality Restaurants Limited156.32+0.91%
- UYFINCORPU. Y. Fincorp Limited22.95-4.30%
- DVLDhunseri Ventures Limited278.60+2.56%
- SHREERAMAShree Rama Multi-Tech Limited43.53+1.02%
- ORBTEXPOrbit Exports Limited246.85+2.68%
- DENORADe Nora India Limited729.10-0.35%
- FILATFASHFilatex Fashions Limited0.180.00%
- AXTELAXTEL447.95+4.08%
- ROLLTRollatainers Limited5.21+4.83%
- BLACKROSEBlack Rose Inds. Limited107.65-2.41%